FibroBiologics News and Activities

FibroBiologics is a company listed under the stock ticker FBLG (US).

View the org chart displaying its 9 main executives

Most searched biographies at FibroBiologics

• Pete O'Heeron, Chief Executive Officer and Chairman of the Board
• Matt Link, Director
• Richard Cilento, Director

Popular executive movements at FibroBiologics

• Kathleen Rubins has joined the company as Director  (posted on July 10 2026).

Create your alert
to follow the executive moves at FibroBiologics.

FibroBiologics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by FibroBiologics

• Houston-based cell therapy company FibroBiologics to go public (updated)
• Press Releases
• Key Leadership Lessons for Biotech Executives from a Hospital Administrator - MedCity News
• Dr. Hamid Khoja: Using Fibroblasts to Treat Chronic Diseases | Docwire News
• Early Promise in Treating MS Seen With FibroBiologic's Fibroblast...
• The 2023 PharmaVoice Year in Preview
• Finding Therapies in Fibroblasts
• Dr. Hamid Khoja: Using Fibroblasts to Treat Chronic Diseases
• News - FibroBiologics
• View more press releases Close

Social media about FibroBiologics

• FibroBiologics on Wikipedia, Google News & Yahoo Finance
• FibroBiologics on LinkedIn, X (Twitter) & YouTube